Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of [18F]FMISO PET/CT in HCC
NCT02695628Phase 2Completed
- Sponsor
- Stanford University
- Start
- Sep 2016
- Primary completion
- Apr 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Stanford University. Primary endpoint: Post-treatment Maximum Standardized Uptake Value (SUVmax) in Tumor and Normal Tissue at 24 hours. Started Sep 2016; status: completed.
Beyond the preview
Go deeper on NCT02695628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695628.